Intravenous administration of Zemaira ™ , 60 mg/kg weekly, has been shown to be generally well tolerated. In clinical studies, the following treatment-related adverse reactions were reported: asthenia , injection site pain , dizziness , headache , paresthesia , and pruritus . Each of these related adverse events was observed in 1 of 89 subjects (1%). The adverse reactions were mild.
... [ read more.. ]
Get A Second Opinion From...
|